© 2002 by European Society of Cardiology
Copyright © 2002, European Society of Cardiology
Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study
aKlinik und Poliklinik für Innere Medizin II, University of Regensburg, Regensburg, Germany
bInstitut für Epidemiologie und Sozialmedizin, University of Münster, Münster, Germany
cGSF Forschungszentrum, Institut für Epidemiologie, München-Neuherberg, Germany
andreas.luchner{at}klinik.uni-regensburg.de
* Corresponding author. Tel.: +49-941-944-7233; fax: +49-941-944-7213
Background: Recent studies suggest that female gender is associated with a lower prevalence and a more benign prognosis of heart failure. In the current population-based study, it was our objective to evaluate the implications of gender on the association between impaired left ventricular (LV) function and mass as well as neurohumoral activation. Methods and results: A total of 1883 subjects (992 female, 891 male) of two MONICA surveys in Augsburg, Germany, were analyzed. Participants of one of these surveys were additionally characterized with respect to neurohormonal activation. As compared to men, women were characterized by a slightly higher LV ejection fraction (EF, Teichholz-Method, 65.4±0.3% vs. 63.4±0.3, P<0.01) and a markedly lower LV mass index (LVMI 81±1 g/m2 vs. 96±1, P<0.01). As compared to men with normal LV function, those with LV dysfunction (EF below mean minus two standard deviations, S.D.) were characterized by significantly increased LV mass (LVMI +48%, P<0.01), plasma BNP (+373%, P<0.01) and ANP (+57%, P<0.01), while no significant changes were observed in women (LVMI +3%, BNP +48%, ANP +27%, all P=n.s). Only a small subgroup of women with severe LVD (EF below mean — 3 S.D.) was characterized by significantly increased LV mass (LVMI +23%, P<0.05 vs. control and LVD), however, this increase was less pronounced as compared to men with severe LVD (LVMI +46%, P<0.01 vs. control). Gender-specific differences between LV function and structure were also confirmed by multivariate analysis. While LVMI was independently and significantly correlated with EF in male subjects in addition to systolic blood pressure, age, and body mass index (all P<0.01), these parameters displaced EF as a predictor of LVMI in female subjects. Conclusions: Men with moderate or severe LV dysfunction are characterized by an increase in both LV mass and cardiac natriuretic peptide plasma concentrations. In contrast, LV mass and natriuretic peptide concentrations increase to a lesser extent and only with severe LV dysfunction in women. These observational data suggest gender-specific control of myocardial adaptations to hemodynamic overload and a more rapid induction of LV hypertrophy during myocardial dysfunction in male subjects.
KEYWORDS Epidemiology; Gender; Hypertrophy; Hypertension; Heart failure; Natriuretic peptide; Ultrasound
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S.-H. Lee, S.-B. Yoon, J.-R. Cho, S. Choi, J.-H. Jung, and N. Lee The Effects of Different {beta}-Blockers on Left-Ventricular Volume and Function After Primary Coronary Stenting in Acute Myocardial Infarction Angiology, January 1, 2009; 59(6): 676 - 681. [Abstract] [PDF]
|
|
|
|
 |
|
 P. M. Okin, E. Gerdts, S. E. Kjeldsen, S. Julius, J. M. Edelman, B. Dahlof, R. B. Devereux, and for the Losartan Intervention for Endpoint Reducti Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy Hypertension, July 1, 2008; 52(1): 100 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Azevedo Gender differences in heart failure Heart, March 1, 2008; 94(3): 264 - 265. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Qiu, B. Tian, R. G. Resuello, F. F. Natividad, A. Peppas, Y.-T. Shen, D. E. Vatner, S. F. Vatner, and C. Depre Sex-specific regulation of gene expression in the aging monkey aorta Physiol Genomics, April 24, 2007; 29(2): 169 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Chung, S. R. Das, D. Leonard, R. M. Peshock, F. Kazi, S. M. Abdullah, R. M. Canham, B. D. Levine, and M. H. Drazner Women Have Higher Left Ventricular Ejection Fractions Than Men Independent of Differences in Left Ventricular Volume: The Dallas Heart Study Circulation, March 28, 2006; 113(12): 1597 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L Golden, J. D Marsh, Y. Jiang, and J. Moulden Acute actions of testosterone on contractile function of isolated rat ventricular myocytes Eur. J. Endocrinol., March 1, 2005; 152(3): 479 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hogenhuis, A. A. Voors, T. Jaarsma, H. L. Hillege, F. Boomsma, and D. J. van Veldhuisen Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP Eur J Heart Fail, January 1, 2005; 7(1): 81 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Hocher, R. Ziebig, R. Krause, G. Asmus, H.-H Neumayer, L. Liefeldt, and J.-P. Stasch Relaxin Is an Independent Risk Factor Predicting Death in Male Patients With End-Stage Kidney Disease Circulation, May 18, 2004; 109(19): 2266 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, I. Kishimoto, Y. Saito, M. Harada, K. Kuwahara, T. Izumi, I. Hamanaka, N. Takahashi, R. Kawakami, K. Tanimoto, et al. Androgen Contributes to Gender-Related Cardiac Hypertrophy and Fibrosis in Mice Lacking the Gene Encoding Guanylyl Cyclase-A Endocrinology, February 1, 2004; 145(2): 951 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Golden, J. D. Marsh, Y. Jiang, T. Brown, and J. Moulden Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E449 - E453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Freitag, M. G. Larson, D. Levy, E. J. Benjamin, T. J. Wang, E. P. Leip, P. W.F. Wilson, and R. S. Vasan Plasma Brain Natriuretic Peptide Levels and Blood Pressure Tracking in the Framingham Heart Study Hypertension, April 1, 2003; 41(4): 978 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fischer, A. Baessler, H.W. Hense, C. Hengstenberg, M. Muscholl, S. Holmer, A. Doring, U. Broeckel, G. Riegger, and H. Schunkert Prevalence of left ventricular diastolic dysfunction in the community: Results from a Doppler echocardiographic-based survey of a population sample Eur. Heart J., February 2, 2003; 24(4): 320 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Crabbe, K. Dipla, S. Ambati, A. Zafeiridis, J. P. Gaughan, S. R. Houser, and K. B. Margulies Gender differences in post-infarction hypertrophy in end-stage failing hearts J. Am. Coll. Cardiol., January 15, 2003; 41(2): 300 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. O. Weinberg, M. Mirotsou, J. Gannon, V. J. Dzau, R. T. Lee, and R. E. Pratt Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload Physiol Genomics, January 15, 2003; 12(2): 113 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Vasan, E. J. Benjamin, M. G. Larson, E. P. Leip, T. J. Wang, P. W. F. Wilson, and D. Levy Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study JAMA, September 11, 2002; 288(10): 1252 - 1259. [Abstract] [Full Text] [PDF]
|
|